Halyard Health, Inc. (NYSE:HYH) updated its FY18 earnings guidance on Wednesday. The company provided earnings per share guidance of $1.85-2.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.04.
A number of equities research analysts have issued reports on the company. Stephens upgraded Halyard Health from an equal weight rating to an overweight rating in a research note on Thursday, August 3rd. Deutsche Bank AG raised their target price on Halyard Health from $35.00 to $42.00 and gave the company a buy rating in a research note on Thursday, August 3rd. TheStreet upgraded shares of Halyard Health from a c rating to a b rating in a research note on Thursday, June 22nd. BidaskClub upgraded shares of Halyard Health from a hold rating to a buy rating in a research note on Wednesday, June 28th. Finally, Zacks Investment Research upgraded shares of Halyard Health from a hold rating to a buy rating and set a $44.00 price objective on the stock in a research note on Wednesday, July 12th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Halyard Health currently has an average rating of Buy and a consensus target price of $42.25.
Shares of Halyard Health, Inc. (HYH) traded up 0.10% during midday trading on Friday, hitting $41.31. 274,902 shares of the company were exchanged. Halyard Health, Inc. has a one year low of $31.59 and a one year high of $43.78. The company’s 50 day moving average price is $40.17 and its 200 day moving average price is $38.81. The firm has a market cap of $1.93 billion, a P/E ratio of 39.72 and a beta of 1.78.
Halyard Health (NYSE:HYH) last issued its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.14. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. The business had revenue of $399.20 million for the quarter, compared to analyst estimates of $399.16 million. During the same quarter in the prior year, the firm posted $0.45 earnings per share. The firm’s revenue for the quarter was down .2% compared to the same quarter last year. Equities analysts expect that Halyard Health, Inc. will post $1.98 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This story was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://www.com-unik.info/2017/08/12/halyard-health-inc-hyh-updates-fy18-earnings-guidance-updated.html.
About Halyard Health
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
What are top analysts saying about Halyard Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Halyard Health Inc. and related companies.